CLINICAL TRIALS PROFILE FOR RUBRACA
✉ Email this page to a colleague
All Clinical Trials for RUBRACA
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02740712 ↗ | Pharmacokinetic Drug-Drug Interaction Study of Rucaparib | Completed | Clovis Oncology, Inc. | Phase 1 | 2016-04-01 | The purpose of this study is to assess pharmacokinetic concentrations of multiple probes alone followed by assessment of the same drug pharmacokinetic concentrations when the patient has steady-state exposure to rucaparib followed by cycle-by-cycle treatment with rucaparib continuing until disease progression or other reason for discontinuation. |
| NCT02855944 ↗ | ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients | Active, not recruiting | Foundation Medicine | Phase 3 | 2017-03-01 | The purpose of this study is to determine how patients with ovarian, fallopian tube, and primary peritoneal cancer will best respond to treatment with rucaparib versus chemotherapy. |
| NCT02855944 ↗ | ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients | Active, not recruiting | Clovis Oncology, Inc. | Phase 3 | 2017-03-01 | The purpose of this study is to determine how patients with ovarian, fallopian tube, and primary peritoneal cancer will best respond to treatment with rucaparib versus chemotherapy. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for RUBRACA
Condition Name
Clinical Trial Locations for RUBRACA
Trials by Country
Clinical Trial Progress for RUBRACA
Clinical Trial Phase
Clinical Trial Sponsors for RUBRACA
Sponsor Name
